News

Filter

Current filters:

OphthalmicsBelgium

Ablynx receives $2.8 million grant to investigate nanobodies in eye disease treatment

Ablynx receives $2.8 million grant to investigate nanobodies in eye disease treatment

18-08-2014

Belgian drug developer Ablynx has received a 2.1 million euro ($2.8 million) grant from the Flemish Agency…

AblynxBelgiumOphthalmicsPharmaceuticalResearch

ThromboGenics announces 2013 growth thanks to Jetrea sales

ThromboGenics announces 2013 growth thanks to Jetrea sales

18-03-2014

Belgium-based biopharma firm ThromboGenics has released its financial results for the full year 2013,…

BelgiumBiotechnologyFinancialJetreaOphthalmicsThromboGenics

ThromboGenics to begin Jetrea study in USA

ThromboGenics to begin Jetrea study in USA

04-03-2014

Belgium-based biopharma firm ThromboGenics will soon initiate a US Phase IV study with Jetrea (ocriplasmin).

AlconBelgiumJetreaOphthalmicsPharmaceuticalResearchThromboGenics

Back to top